Melt Your Valentine’s Heart with Gardners Original Peanut Butter Meltaways, Other Seasonal Specialties

TYRONE, Penn., Feb. 07, 2025 (GLOBE NEWSWIRE) — From fresh chocolate covered strawberries to heart shaped Original Peanut Butter Meltaways, legendary Pennsylvania chocolatier Gardners Candies has more than a dozen Valentine's Day treats ready for nationwide shipping. To make the holiday even sweeter, Gardners is offering a 15% discount, good through February 14. Use promo […]

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

(NASDAQ:ELDN), Patient treated in procedure, conducted at Mass General Transplant Center and in collaboration with partner eGenesis, was recently released from hospital Investigational therapy tegoprubart targets CD40 ligand (CD40L) with potential to improve both safety and efficacy compared to standard of care immunosuppression regimens IRVINE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc.

Endeavour to announce its Q4 and FY-2024 results on 6 March 2025

(LSE:EDV),(TSX-V:EDV),(OTC US:EDVMF),(OTCQX:EDVMF), ENDEAVOUR TO ANNOUNCE ITS Q4 AND FY-2024 RESULTS ON 6 MARCH 2025 London, 7 February 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) expects to release its Q4 and FY-2024 financial results on Thursday 6 March 2025, before the LSE market open. Management will host a conference call and webcast on the same

LifeNet Health Achieves Its 7th Record-Breaking Year in Organ Donation

LifeNet Health's Organ Procurement Organization (OPO) is proud to mark another milestone in its mission to save and improve lives. In 2024, LifeNet Health achieved its seventh record-breaking year in the past eight years with 299 donors providing 857 organs for transplant, a remarkable 25% increase over the previous year. This achievement reflects the unwavering

SunCar Technology Group Announces Share Repurchase Program

SunCar Technology Group Inc. (“SunCar” or the “Company”) (Nasdaq: SDA), an innovative leader in cloud-based B2B auto services and auto e-insurance in China, today announced that its board of directors has authorized a share repurchase program to buy back up to $30 million of its outstanding Class A ordinary shares. This program reflects the Company's

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

CHICAGO, IL / ACCESS Newswire / February 7, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its wholly owned

ATTENTION Universal Display Corporation Investors: You May Have Been Affected by Fraud – Contact Levi & Korsinsky to Discuss Your Rights

NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Universal Display Corporation ("Universal Display Corporation") (NASDAQ:OLED) concerning possible violations of federal securities laws. On August 1, 2024, Universal reported solid 2Q 2024 results and raised the bottom-end of its full year

The All-New Dave & Buster’s Launches in Marietta on February 21

Grab Your Crew – the First 100 People in Line at the Grand Opening to Receive Free Games for a Year! Today,Dave & Buster's, the ultimate entertainment, restaurant, and sports watching destination for families and friends, announces the opening of its completely reimagined location in Marietta, GA at 2215 D&B Drive on Friday, February 21.

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Transocean

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Transocean To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Transocean between October 31, 2023 and September 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In AstraZenecaTo Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi

Scroll to Top